An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension

NCT02969265 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business reasons unrelated to product safety

Conditions

Hypertension

Interventions

DRUG: Amlodipine
DRUG: TCV-116CCB
DRUG: Amlodipine Placebo
DRUG: TCV-116CCB Placebo

Sponsor

Takeda